The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality
Open accessAbstract
In this international study, we examined the incidence of hip fractures, postfracture treatment, and all‐cause mortality following hip fractures, based on demographics, geography, and calendar year. We used patient‐level healthcare data from 19 countries and regions to identify patients aged 50 years and older hospitalized with a hip fracture from 2005 to 2018. The age‐ and sex‐standardized incidence rates of hip fractures, post‐hip fracture treatment (defined as the proportion of patients receiving anti‐osteoporosis medication with various mechanisms of action [bisphosphonates, denosumab, raloxifene, strontium ranelate, or teriparatide] following a hip fracture), and the all‐cause mortality rates after hip fractures were estimated using a standardized protocol and common data model. The number of hip fractures in 2050 was projected based on trends in the incidence and estimated future population demographics. In total, 4,115,046 hip fractures were identified from 20 databases. The reported age‐ and sex‐standardized incidence rates of hip fractures ranged from 95.1 (95% confidence interval [CI] 94.8–95.4) in Brazil to 315.9 (95% CI 314.0–317.7) in Denmark per 100,000 population. Incidence rates decreased over the study period in most countries; however, the estimated total annual number of hip fractures nearly doubled from 2018 to 2050. Within 1 year following a hip fracture, post‐hip fracture treatment ranged from 11.5% (95% CI 11.1% to 11.9%) in Germany to 50.3% (95% CI 50.0% to 50.7%) in the United Kingdom, and all‐cause mortality rates ranged from 14.4% (95% CI 14.0% to 14.8%) in Singapore to 28.3% (95% CI 28.0% to 28.6%) in the United Kingdom. Males had lower use of anti‐osteoporosis medication than females, higher rates of all‐cause mortality, and a larger increase in the projected number of hip fractures by 2050. Substantial variations exist in the global epidemiology of hip fractures and postfracture outcomes. Our findings inform possible actions to reduce the projected public health burden of osteoporotic fractures among the aging population. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Self-citationReitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Self-citationA century of trends in adult human height
NCD Risk Factor Collaboration (NCD-RisC) (2016) · eLife · doi:10.7554/elife.13410 · Cited by 1,558
A systematic review of hip fracture incidence and probability of fracture worldwide
Kanis, J. A., Odén, A., McCloskey, E. V., Johansson, H., Wahl, D. A., Cooper, C., & on behalf of the IOF Working Group on Epidemiology and Quality of Life (2012) · Osteoporosis International · doi:10.1007/s00198-012-1964-3 · Cited by 1,379
Self-citationWu, A.-M., Bisignano, C., James, S. L., Abady, G. G., Abedi, A., Abu-Gharbieh, E., Alhassan, R. K., Alipour, V., Arabloo, J., Asaad, M., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00172-0 · Cited by 1,291
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
A critical review of the long-term disability outcomes following hip fracture
for the Fragility Fracture Network (FFN) Rehabilitation Research Special Interest Group, Dyer, S. M., Crotty, M., Fairhall, N., Magaziner, J., Beaupre, L. A., Cameron, I. D., & Sherrington, C. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0332-0 · Cited by 977
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Secular trends in the incidence of hip and other osteoporotic fractures
The IOF CSA Working Group on Fracture Epidemiology, Cooper, C., Cole, Z. A., Holroyd, C. R., Earl, S. C., Harvey, N. C., Dennison, E. M., Melton, L. J., Cummings, S. R., & Kanis, J. A. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1601-6 · Cited by 914
Self-citationSCOPE 2021: a new scorecard for osteoporosis in Europe
Kanis, J. A., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Willers, C., & Borgström, F. (2021) · Archives of Osteoporosis · doi:10.1007/s11657-020-00871-9 · Cited by 714
Ström, O., Borgström, F., Kanis, J. A., Compston, J., Cooper, C., McCloskey, E. V., & Jönsson, B. (2011) · Archives of Osteoporosis · doi:10.1007/s11657-011-0060-1 · Cited by 546
Self-citationIOF Fracture Working Group, Åkesson, K., Marsh, D., Mitchell, P. J., McLellan, A. R., Stenmark, J., Pierroz, D. D., Kyer, C., & Cooper, C. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2348-z · Cited by 521
Self-citationAtypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates
Black, D. M., Geiger, E. J., Eastell, R., Vittinghoff, E., Li, B. H., Ryan, D. S., Dell, R. M., & Adams, A. L. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916525 · Cited by 407
Geographic and ethnic disparities in osteoporotic fractures
Cauley, J. A., Chalhoub, D., Kassem, A. M., & Fuleihan, G. E.-H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.51 · Cited by 376
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
Shepstone, L., Lenaghan, E., Cooper, C., Clarke, S., Fong-Soe-Khioe, R., Fordham, R., Gittoes, N., Harvey, I., Harvey, N., Heawood, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32640-5 · Cited by 298
Self-citationHip fracture trends in the United States, 2002 to 2015
Michael Lewiecki, E., Wright, N. C., Curtis, J. R., Siris, E., Gagel, R. F., Saag, K. G., Singer, A. J., Steven, P. M., & Adler, R. A. (2018) · Osteoporosis International · doi:10.1007/s00198-017-4345-0 · Cited by 279
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition
Conley, R. B., Adib, G., Adler, R. A., Åkesson, K. E., Alexander, I. M., Amenta, K. C., Blank, R. D., Brox, W. T., Carmody, E. E., Chapman-Novakofski, K., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3877 · Cited by 242
Self-citationJha, S., Wang, Z., Laucis, N., & Bhattacharyya, T. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2565 · Cited by 230
Secular Trends in Hip Fractures Worldwide: Opposing Trends East Versus West
Ballane, G., Cauley, J. A., Luckey, M. M., & Fuleihan, G. E.-H. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2218 · Cited by 195
Excess Mortality or Institutionalization After Hip Fracture: Men Are at Greater Risk Than Women
Fransen, M., Woodward, M., Norton, R., Robinson, E., Butler, M., & Campbell, A. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50163.x · Cited by 178
Shane, E. J., Burr, D. B., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R. M., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.416 · Cited by 144
Javaid, M. K., Sami, A., Lems, W. F., Mitchell, P., Thomas, T., Singer, A. J., Speerin, R., Fujita, M., Pierroz, D. D., Åkesson, K., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05377-1 · Cited by 137
Self-citationLi, N., Hiligsmann, M., Boonen, A. E. R. C. H., van Oostwaard, M. M., de Bot, R. T. A. L., Wyers, C. E., Bours, S., & van den Bergh, J. P. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05911-9 · Cited by 137
van der Velde, R. Y., Wyers, C. E., Teesselink, E., Geusens, P., van den Bergh, J. P., de Vries, F., Cooper, C. C., Harvey, N. C., & van Staa, T. P. (2016) · Bone · doi:10.1016/j.bone.2016.10.013 · Cited by 84
Self-citationthe EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs, Seppala, L. J., the EuGMS Special Interest Group on Pharmacology, van der Velde, N., Masud, T., Blain, H., Petrović, M., van der Velde, N., Szczerbińska, K. E., Hartikainen, S. A., et al. (2019) · Drugs & Aging · doi:10.1007/s40266-018-0622-7 · Cited by 68
Self-citationSing, C., Lin, T., Bartholomew, S., Bell, J. S., Bennett, C., Beyene, K. A., Bosco‐Lévy, P., Chan, A. H. Y., Chandran, M., Cheung, C., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047258 · Cited by 57
Self-citationthe EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs, Seppala, L. J., the EuGMS Special Interest Group on Pharmacology, van der Velde, N., Masud, T., Blain, H., Petrović, M., van der Velde, N., Szczerbińska, K. E., Hartikainen, S. A., et al. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00162-8 · Cited by 45
Self-citationSkjødt, M. K., Khalid, S., Ernst, M., Rubin, K. H., Martínez-Laguna, D., Delmestri, A., Javaid, M. K., Cooper, C. C., Libanati, C. R., Tóth, E., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05358-4 · Cited by 45
Self-citationZhou, W. Z., Langsetmo, L., Berger, C., Poliquin, S., Kreiger, N., Barr, S. I., Kaiser, S., Josse, R. G., Prior, J. C., Towheed, T., et al. (2013) · PubMed · Cited by 34
Skjødt, M. K., Ernst, M. T., Khalid, S., Libanati, C. R., Cooper, C. C., Delmestri, A., Rubin, K. H., Javaid, M. K., Martínez-Laguna, D., Tóth, E., et al. (2021) · Osteoporosis International · doi:10.1007/s00198-021-05890-x · Cited by 29
Self-citation
Metadata
- Authors
- Sing, C., Lin, T., Bartholomew, S., Bell, J. S., Bennett, C., Beyene, K., Bosco‐Levy, P., Bradbury, B. D., Chan, A. H. Y., Chandran, M., Cooper, C., de Ridder, M., Doyon, C. Y., Droz‐Perroteau, C., Ganesan, G., Hartikainen, S., Ilomaki, J., Jeong, H. E., Kiel, D. P., Kubota, K., Lai, E. C., Lange, J. L., Lewiecki, E. M., Lin, J., Liu, J., Maskell, J., de Abreu, M. M., O'Kelly, J., Ooba, N., Pedersen, A. B., Prats‐Uribe, A., Prieto‐Alhambra, D., Qin, S. X., Shin, J., Sørensen, H. T., Tan, K. B., Thomas, T., Tolppanen, A., Verhamme, K. M. C., Wang, G. H., Watcharathanakij, S., Wood, S. J., Cheung, C., & Wong, I. C. K.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-05-29
- Volume
- 38
- Issue
- 8
- Pages
- 1064-1075
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W4367369432
- Cited by
- 623
- References
- 32
- FWCI
- 148.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.